Physician profile
Eric Lam
NPI 1821599069
$6,667.28
in general payments reported to CMS, 2019-2025
19 companies · $2,128 in 2025
The $2,128 reported for 2025 was more than what 79% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2021: $122 · 2022: $385 · 2023: $2,788 · 2024: $1,096 · 2025: $2,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,168 · Food and Beverage: $2,769 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,167.50 |
| Food and Beverage | $2,768.81 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,288.87 | 2023-2024 | Proclaim, Eterna |
| Boston Scientific Corporation | $2,232.65 | 2024-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Relievant Medsystems, INC. | $385.60 | 2022-2023 | Intracept |
| Vertos Medical, INC. | $362.10 | 2023-2024 | Mild Device Kit |
| Abbvie INC. | $250.00 | 2023 | |
| Saluda Medical Americas, INC. | $229.88 | 2024 | Evoke |
| Nalu Medical, INC. | $161.67 | 2023-2024 | Nalu Neurostimulation System |
| Painteq LLC | $134.92 | 2024 | Painteq |
| Curonix LLC | $129.85 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Allergan, INC. | $124.99 | 2022 | |
| Amneal Pharmaceuticals LLC | $118.15 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.48 | 2021 | |
| Redhill Biopharma INC. | $49.67 | 2021 | |
| Pfizer INC. | $32.60 | 2025 | |
| Spr Therapeutics, INC | $22.97 | 2024 | Sprint Pns System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $21.26 | 2022 | |
| Biotronik Nro, INC. | $18.87 | 2025 | Prospera |
| Acorda Therapeutics, INC | $16.60 | 2019 | |
| Lilly USA, LLC | $14.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.